Increased expression of FH and FHL-1 by tumor cells as a protective measure against complement-mediated damage and killing – in addition to the upregulation of cell membrane-anchored complement inhibitory proteins – is known for long (142–145). The gene discussed is FH; the disease is neoplasm.